General Information of Drug (ID: DMT4RI2)

Drug Name
Isoquinoline-1,3,4(2H)-trione Drug Info
Synonyms
Phthalonimide; 1,3,4(2H)-Isoquinolinetrione; isoquinoline-1,3,4(2H)-trione; 521-73-3; isoquinoline-1,3,4-trione; 1,3,4-(2H)ISOQUINOLINETRIONE; UNII-BM68CV5X6Q; NSC 407248; BRN 0383773; BM68CV5X6Q; 1,2,3,4-tetrahydroisoquinoline-1,3,4-trione; isoquinoline-1,3,4-(2H)-trione; 3deh; NSC407248; AC1L1VMV; 5-21-11-00575 (Beilstein Handbook Reference); 1,4(2H)-Isoquinolinetrione; SCHEMBL1122624; Isoquinoline-1,3,4-trione 1; CHEMBL206435; CTK1H0848; BDBM10247; DTXSID40200103; ZINC1599708; FCH844329; ACM521733; AKOS006276226; NSC-407248
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
10640
CAS Number
CAS 521-73-3
TTD Drug ID
DMT4RI2

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Clinical Trial Drug(s)
Preclinical Drug(s)
Discontinued Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ISIS 134602 DMDS4BP Discovery agent N.A. Investigative [2]
ISIS 134583 DM0HWRN Discovery agent N.A. Investigative [2]
ISIS 134566 DMCM2S4 Discovery agent N.A. Investigative [2]
ISIS 134524 DMFCOA5 Discovery agent N.A. Investigative [2]
ISIS 134532 DMRFMVL Discovery agent N.A. Investigative [2]
Ac-VEID-CHO DMWOYCZ Discovery agent N.A. Investigative [3]
ISIS 134609 DMYODMN Discovery agent N.A. Investigative [2]
ISIS 134608 DMVX9IT Discovery agent N.A. Investigative [2]
ISIS 134499 DM90TOR Discovery agent N.A. Investigative [2]
ISIS 134528 DMYZNIW Discovery agent N.A. Investigative [2]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Acetyl-Ile-Glu-Thr-Asp-aldehyde DM1VE6S Discovery agent N.A. Investigative [3]
ISIS 107612 DMBWCZR Discovery agent N.A. Investigative [4]
ISIS 107676 DMUE64H Discovery agent N.A. Investigative [4]
ISIS 107681 DMB9VFS Discovery agent N.A. Investigative [4]
ISIS 107652 DMOX8JF Discovery agent N.A. Investigative [4]
ISIS 107642 DMPR7OD Discovery agent N.A. Investigative [4]
⏷ Show the Full List of 6 Drug(s)
Drug(s) Targeting Caspase-3 (CASP3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PAC1 DMYQUIP Anaplastic astrocytoma 2A00.0 Phase 1 [5]
M826 DM9NPE4 Discovery agent N.A. Investigative [6]
Glionitrin A DM98CSW Solid tumour/cancer 2A00-2F9Z Investigative [7]
Ac-DEVD-CHO DMW02H7 Discovery agent N.A. Investigative [8]
5-(piperidin-1-ylsulfonyl)indoline-2,3-dione DMT60AM Discovery agent N.A. Investigative [9]
SJ-8002 DMEQBU2 Solid tumour/cancer 2A00-2F9Z Investigative [10]
AZ10417808 DMNO6PL Discovery agent N.A. Investigative [11]
2-phenethylisoquinoline-1,3,4-trione DMPWG21 Discovery agent N.A. Investigative [1]
2-benzylisoquinoline-1,3,4-trione DME7SAV Discovery agent N.A. Investigative [1]
2-(4-methoxy-benzyl)isoquinoline-1,3,4-trione DMHAE31 Discovery agent N.A. Investigative [1]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Targeting Caspase (CASP)
Drug Name Drug ID Indication ICD 11 Highest Status REF
NCX-1000 DM2YIZH Cardiovascular disease BA00-BE2Z Phase 2 [12]
Z-VAD-fmk DMTDG7L Pulmonary fibrosis CB03.4 Preclinical [13]
VX-166 DMZKY56 Hepatic fibrosis DB93.0 Preclinical [14]
ALS-769 DMGBT9Z Solid tumour/cancer 2A00-2F9Z Terminated [15]
Ac-DEVD-CHO DMW02H7 Discovery agent N.A. Investigative [8]
2-aminophenoxazine-3-one DMBVGAO T-cell leukaemia 2A90 Investigative [16]
IDN-1965 DMRQSN2 Discovery agent N.A. Investigative [17]
⏷ Show the Full List of 7 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Caspase (CASP) TTZY5KP NOUNIPROTAC Inhibitor [1]
Caspase 6 messenger RNA (CASP6 mRNA) TTKW4ML CASP6_HUMAN Inhibitor [1]
Caspase 8 messenger RNA (CASP8 mRNA) TT6SZNG CASP8_HUMAN Inhibitor [1]
Caspase-3 (CASP3) TTPF2QI CASP3_HUMAN Inhibitor [1]

References

1 Design, synthesis, and biological evaluation of isoquinoline-1,3,4-trione derivatives as potent caspase-3 inhibitors. J Med Chem. 2006 Mar 9;49(5):1613-23.
2 US patent application no. 6,566,135, Antisense modulation of caspase 6 expression.
3 Synthesis and in vitro evaluation of sulfonamide isatin Michael acceptors as small molecule inhibitors of caspase-6. J Med Chem. 2009 Apr 23;52(8):2188-91.
4 US patent application no. 6,258,600, Antisense modulation of caspase 8 expression.
5 Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy. Nat Chem Biol. 2006 Oct;2(10):543-50.
6 Novel pyrazinone mono-amides as potent and reversible caspase-3 inhibitors. Bioorg Med Chem Lett. 2005 Feb 15;15(4):1173-80.
7 Glionitrin A, a new diketopiperazine disulfide, activates ATM-ATR-Chk1/2 via 53BP1 phosphorylation in DU145 cells and shows antitumor effect in xenograft model. Biol Pharm Bull. 2014;37(3):378-86.
8 Synthesis and evaluation of vinyl sulfones as caspase-3 inhibitors. A structure-activity study. Eur J Med Chem. 2010 Sep;45(9):3858-63.
9 Design, synthesis, and discovery of novel non-peptide inhibitor of Caspase-3 using ligand based and structure based virtual screening approach. Bioorg Med Chem. 2009 Aug 15;17(16):6040-7.
10 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1619).
11 Novel small molecule inhibitors of caspase-3 block cellular and biochemical features of apoptosis. J Pharmacol Exp Ther. 2003 Jan;304(1):433-40.
12 Liver delivery of NO by NCX-1000 protects against acute liver failure and mitochondrial dysfunction induced by APAP in mice. Br J Pharmacol. 2004 Sep;143(1):33-42.
13 Clinical pipeline report, company report or official report of InvivoGen.
14 VX-166: a novel potent small molecule caspase inhibitor as a potential therapy for sepsis. Crit Care. 2009;13(5):R146.
15 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025089)
16 Apoptosis as a mechanism for the treatment of adult T cell leukemia: promising drugs from benchside to bedside. Drug Discov Today. 2020 Jul;25(7):1189-1197.
17 Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Galpha(q) transgenic ... Circulation. 2003 Dec 16;108(24):3036-41.